TRUL — Trulieve Cannabis Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapContrarian

Annual income statement for Trulieve Cannabis, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	938	1,218	1,129	1,186	1,181
Cost of Revenue
Gross Profit	569	695	593	716	711
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	738	1,168	1,345	1,089	1,039
Operating Profit	200	50.2	-216	97.8	142
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	166	-19.2	-285	42.7	91.5
Provision for Income Taxes
Net Income After Taxes	19.6	-181	-433	-155	-117
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	18	-246	-527	-155	-116
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	18	-246	-527	-155	-116
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.194	-0.656	-1.19	-0.742	-0.512